Develops creams and foams for skin diseases like psoriasis and atopic dermatitis.
Jun 2026Revenue $464M/yrExpenses $430M/yr
Reached break-even Mar 2026
Figures by year
When did Arcutis Biotherapeutics become profitable?
Its revenue passed its expenses in Mar 2026. In the 12 months to Jun 2026, revenue was $464M and expenses $430M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $376M | $388M | −$12.2M |
| Dec 2024 | $197M | $325M | −$128M |
| Dec 2023 | $59.6M | $301M | −$241M |
| Dec 2022 | $3.69M | $305M | −$302M |
| Dec 2021 | $0.00 | $207M | −$207M |
| Dec 2020 | $0.00 | $137M | −$137M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.